Study of the Effect on Clinical Outcomes Using Secure Text Messaging

NCT02568514 | Withdrawn

• 1 other identifier: 823096
• Study Type: interventional
• Target: N/A
• Locations: 1 country
• Sites: 1

Brief Summary

In this study, the investigators will conduct a randomized, controlled trial to evaluate the impact of offering mobile secure text messaging on clinical outcomes.

Conditions

Congestive Heart Failure; Diabetes; Renal Failure; Copd

Keywords

mhealth; text messaging; secure text messaging; communication

Outcome Measures

Primary Outcomes (3)

• Change in length of stay

  Change in inpatient length of stay from baseline to 6 months

  6 months

• Change in 30 day hospital readmissions

  Change in 30 day hospital readmissions from baseline to 6 months

  6 months

• Change in inpatient mortality

  Change in inpatient mortality from baseline to 6 months

  6 months

Secondary Outcomes (1)

• Change in Hospital Consumer Assessment of Healthcare Providers and Systems (HCAPs) scores

  6 months

Study Arms (2)

Usual care

NO INTERVENTION

Patients admitted to hospital floors without any other intervention.

Secure text messaging

EXPERIMENTAL

Patients admitted to hospital floors on which physicians and other staff are able to communicate with each other (not to the patient) using mobile secure text messaging.

Device: Secure text messaging

Interventions

Secure text messaging DEVICE

A smartphone and web application that allows physicians and other health care professionals to communicate to each other by secure text message

Secure text messaging

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Healthy Volunteers: Yes
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• Admission to one of the hospital floors or services in the study at the Hospital of the University of Pennsylvania

You may not qualify if:

• Discharges against medical advice
• Discharges to hospice

Sponsors & Collaborators

• University of Pennsylvania: lead

Study Sites (1)

University of Pennsylvania

Philadelphia, Pennsylvania, 19104, United States

Location

MeSH Terms

Conditions

Heart Failure; Diabetes Mellitus; Renal Insufficiency; Pulmonary Disease, Chronic Obstructive; Communication

Condition Hierarchy (Ancestors)

Heart Diseases; Cardiovascular Diseases; Glucose Metabolism Disorders; Metabolic Diseases; Nutritional and Metabolic Diseases; Endocrine System Diseases; Kidney Diseases; Urologic Diseases; Female Urogenital Diseases; Female Urogenital Diseases and Pregnancy Complications; Urogenital Diseases; Male Urogenital Diseases; Lung Diseases, Obstructive; Lung Diseases; Respiratory Tract Diseases; Chronic Disease; Disease Attributes; Pathologic Processes; Pathological Conditions, Signs and Symptoms; Behavior

Study Officials

• Mitesh Patel, MD, MBA, MS

  University of Pennsylvania

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: RANDOMIZED
• Masking: SINGLE
• Who Masked: INVESTIGATOR
• Purpose: HEALTH SERVICES RESEARCH
• Intervention Model: PARALLEL
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: October 2, 2015
• First Posted: October 6, 2015
• Study Start: August 1, 2016
• Primary Completion: March 1, 2017
• Study Completion: March 1, 2017
• Last Updated: April 10, 2017

Record last verified: 2017-04

Locations

US (1)